Get 20% lifetime commission for referring investors to digrin.com
here.
Kintara Therapeutics, Inc. (KTRA) Financials
Stock symbol KTRA is outdated, potentially delisted? Maybe it is available on other exchange?
KTRA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 1.9 million | 2.0 million |
| Sept. 30, 2023 | 1.5 million | 3.5 million |
| June 30, 2023 | 4.0 million | 3.2 million |
| March 31, 2023 | 6.7 million | 3.0 million |
KTRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -2.1 million | 165000 |
| Sept. 30, 2023 | -1.3 million | 160000 |
| June 30, 2023 | -1.5 million | 246000 |
| March 31, 2023 | -1.8 million | 290000 |
KTRA Net Income
No data available :(
KTRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 658000 | - | - |
| Sept. 30, 2023 | 216000 | - | - |
| June 30, 2023 | 1.5 million | - | - |
| March 31, 2023 | 3.0 million | - | - |
KTRA Shares Outstanding
KTRA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 20000 | 111000 | 908000 | 15000 |
| Sept. 30, 2023 | - | 1.9 million | 1.1 million | - |
| June 30, 2023 | - | 2.1 million | 1.3 million | - |
| March 31, 2023 | - | 2.0 million | 1.3 million | - |
KTRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 15000 |
| Sept. 30, 2023 | - | 15000 |
| June 30, 2023 | - | 15000 |
| March 31, 2023 | - | 15000 |
KTRA
Price: $0.22
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 62500
Market Capitalization: 10.5 million